Cancer Stem Cell & Oncology Research

Dr. Mariana Argenziano is a Research Associate faculty at the University of Florida’s Heart Institute and Morsani College of Medicine. She has received a PhD from the University of San Martin (Buenos Aires, Argentina) in 2014 and trained as a postdoctoral researcher at the Universities of Illinois and Pennsylvania.

Cardiovascular regenerative medicine Development of organoids models for cardiac disease Effect of air pollution on cardiovascular disease

Dr. Ebrahim Mostafavi is currently at Stanford Cardiovascular Institute, School of Medicine. His research interests revolve around the use of cardiac iPS cells to design and develop in vitro models for cardiovascular disease modeling and drug screening. Dr. Mostafavi received his PhD in Chemical Engineering (with a focus on Biomedical Engineering, Biomaterials, Tissue Engineering and Regenerative Medicine) from Northeastern University, Boston, MA. During his doctoral training, he received several prestigious awards. Dr. Mostafavi serves as an Associate Editor-in-Chief for the International Journal of Nanomedicine (IF= 5.115, 5-year IF= 5.166, Q1 Bioengineering). He also serves as a verified peer-reviewed (50+ documents) for over 18 different high-impact journals from prestigious publishers such as Nature, Elsevier, Springer Nature, Wiley, Taylor & Francis, Dove Press, PLOS, IOPscience, etc. His scholarly work consists of > 40 publications with an H-index of 17 (i10-index= 22) on Google Scholar Profile. He also contributed to 7 book chapters and was selected as the editor of a few books, including “Advances in Cardiovascular Biomaterials” and "Emerging Nanomaterials to Combat Antimicrobial Resistance.

Dr. Ebrahim Mostafavi research interests revolve around the use of cardiac iPS cells to design and develop in vitro models for cardiovascular disease modeling and drug screening

Marek Malecki MD PhD is President of Phoenix Biomolecular Engineering Foundation, Chief Executive Officer of the Center for Molecular Medicine, and Visiting Professor at the University of Wisconsin. He earned MD degree at the Medical Academy, Poznan followed by Residency/Fellowship in Molecular Medicine in Rigshospitalet, Copenhagen. He earned PhD at the National Academy of Sciences, Warsaw followed by the postdoctoral fellowships in molecular biology at the Austrian Academy of Sciences, Karolinska Institutet, Stockholm, Salzburg and Vienna, ETH, Zurich, Utrecht University Medical School, Utrecht, Cancer Center, Vienna, Cancer Center, Amsterdam, Biozentrum, Basel. Dr Malecki developed a novel technology to identify and isolate single living pluripotent stem cells followed by their clonal expansion and molecular profiling including sequencing their proteomes, transcriptomes, and genomes. This technology serves also for reprogramming the stem cells for their use as the vectors in gene therapy of cancer. The technology, protected by the US and WIPO, is currently streamlined to clinical trials. He is the first author on the peer-reviewed articles. He is often an invited speaker and courses’ faculty at the international professional conferences. Dr Malecki is Editor in Chief of the Journal of Genetic Syndromes and Gene Therapy and Member of the Editorial Boards for many high-impact professional journals. He is the member of the American Medical Association, American Association of Human Genetics, American Antibody Society, Southern California Biotechnology Council, and Rho Chi Honor Society for Excellence in Teaching and as the Faculty Role Model.

cancers of ovaries, cancers of testes, cancer stem cells (CSC), circulating tumor cells (CTCs), genetic disorders, iatrogenic genetic mutations, gene therapy, targeted gene delivery, fertility sparing therapy, biobanking, in vitro fertilization.

Alex F. Chen is Director of VA Vascular Surgery Research, and an Associate Professor, Department of Surgery, University of Pittsburgh School of Medicine. He has received a MD from Hunan Medical University in 1985 and a PhD in Pharmacology from Southern Illinois University in 1995. He is serving as an editorial board member of several reputed journals.

Vascular and endothelial cell biology Endothelial progenitor cells Redox regulation of endothelial function in diabetes and hypertension.